Published in Gene Therapy Weekly, July 27th, 1998
R. Dummer and colleagues from the University of Zurich Medical School, and the Basel Institute for Immunology, Switzerland, analyzed the immunostimulatory potential of B7.1- and B7.2-transduced human melanoma cell lines ("Immune Stimulatory Potential of B7.1 and B7.2 Retrovirally Transduced Melanoma Cells: Suppression by Interleukin 10," British Journal of Cancer, May 1998;77(9):1413-9).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.